Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul A Renauer

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Clinical Immunology (Orlando, Fla.)|December 3, 2014
The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune responsePaul A Renauer, Patrick Coit, Amr H Sawalha
Immunological Reviews|July 14, 2023
Applications of CRISPR technology in cellular immunotherapyXiaoyu Zhou, Paul A Renauer, Liqun Zhou, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapyNipun Verma, Paul A Renauer, Chuanpeng Dong, et al.
Cell Chemical Biology|January 14, 2023
RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seqPing Ren, Lei Peng, Luojia Yang, et al.
Cell Research|March 6, 2023
Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigensZhenhao Fang, Valter S Monteiro, Paul A Renauer, et al.
Cell Reports|August 3, 2022
Multiplexed LNP-mRNA vaccination against pathogenic coronavirus speciesLei Peng, Zhenhao Fang, Paul A Renauer, et al.
Nature Immunology|July 27, 2023
CTLA-4 tail fusion enhances CAR-T antitumor immunityXiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
CTLA-4 tail fusion enhances CAR-T anti-tumor immunityXiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Perturbomics of tumor-infiltrating NK cellsLei Peng, Paul A Renauer, Lupeng Ye, et al.
Cell Reports. Medicine|May 13, 2022
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2Lei Peng, Paul A Renauer, Arya Ökten, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|December 3, 2014
The DNA methylation signature of human TCRαβ+CD4-CD8- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune responsePaul A Renauer, Patrick Coit, Amr H Sawalha
Immunological Reviews|July 14, 2023
Applications of CRISPR technology in cellular immunotherapyXiaoyu Zhou, Paul A Renauer, Liqun Zhou, et al.
Biorxiv : the Preprint Server for Biology|January 31, 2024
Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapyNipun Verma, Paul A Renauer, Chuanpeng Dong, et al.
Cell Chemical Biology|January 14, 2023
RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seqPing Ren, Lei Peng, Luojia Yang, et al.
Cell Research|March 6, 2023
Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigensZhenhao Fang, Valter S Monteiro, Paul A Renauer, et al.
Cell Reports|August 3, 2022
Multiplexed LNP-mRNA vaccination against pathogenic coronavirus speciesLei Peng, Zhenhao Fang, Paul A Renauer, et al.
Nature Immunology|July 27, 2023
CTLA-4 tail fusion enhances CAR-T antitumor immunityXiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
CTLA-4 tail fusion enhances CAR-T anti-tumor immunityXiaoyu Zhou, Hanbing Cao, Shao-Yu Fang, et al.
Biorxiv : the Preprint Server for Biology|March 30, 2023
Perturbomics of tumor-infiltrating NK cellsLei Peng, Paul A Renauer, Lupeng Ye, et al.
Cell Reports. Medicine|May 13, 2022
Variant-specific vaccination induces systems immune responses and potent in vivo protection against SARS-CoV-2Lei Peng, Paul A Renauer, Arya Ökten, et al.
Pageof 3